GlassScriptPhysician profile
Scott D Mclain
NPI 1285664839
$1,347.48
in general payments reported to CMS, 2019-2025
23 companies · $59.64 in 2025
The $59.64 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $240 · 2020: $420 · 2021: $376 · 2022: $111 · 2024: $140 · 2025: $59.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $199.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $271.34 | 2019-2025 | Airsupra, Breztri |
| Amgen INC. | $198.19 | 2019-2024 | Krystexxa, Tavneos |
| Novo Nordisk INC | $98.31 | 2019-2021 | |
| Pfizer INC. | $90.49 | 2019-2024 | |
| Glaxosmithkline, LLC. | $84.17 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $77.91 | 2021-2022 | |
| Esperion Therapeutics, INC. | $74.59 | 2021 | |
| Amarin Pharma, INC. | $67.41 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $56.16 | 2021-2022 | |
| Philips North America LLC | $36.88 | 2024 | (Ck7) Extended Holter |
| Abbvie INC. | $34.37 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $34.27 | 2022 | |
| Lilly USA, LLC | $31.98 | 2021 | |
| Allergan, INC. | $28.91 | 2020 | |
| Nestle Healthcare Nutrition INC. | $28.01 | 2020-2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $23.72 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $20.98 | 2020 | |
| Horizon Therapeutics Plc | $20.21 | 2022 | |
| Optos, INC. | $15.47 | 2019 | |
| Exact Sciences Corporation | $14.31 | 2025 | The Cologuard Plus Collection Kit |
| Eisai INC. | $14.18 | 2021 | |
| Circassia INC. | $13.14 | 2019 | |
| Janssen Pharmaceuticals, INC | $12.48 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Mclain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.